28 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Novo Nordisk A/S | 27 |
| Novo Nordisk Health Care AG | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19422732 | Untitled | Novo Nordisk A/S | HA, JULIE | 1654 | Non-Final OA | |
| 19419518 | Untitled | Novo Nordisk A/S | SHIAO, REI TSANG | 1691 | Non-Final OA | |
| 19310993 | SEMAGLUTIDE FOR USE IN MEDICINE | Novo Nordisk A/S | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Aug 27, 2025 |
| 18874891 | SYSTEMS AND METHODS FOR REGIMEN ADHERENCE EVALUATION | Novo Nordisk A/S | LAGOY, KYRA RAND | 3685 | Non-Final OA | Dec 13, 2024 |
| 18578485 | SODIUM N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLATE POLYMORPHIC FORM A | Novo Nordisk A/S | MCKOY, QUINCY ANDRE | 1626 | Non-Final OA | Jan 11, 2024 |
| 18577720 | TABLET COMPRISING A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | Novo Nordisk A/S | CHANG, KYUNG SOOK | 1613 | Non-Final OA | Jan 09, 2024 |
| 18576838 | METHOD FOR PROVIDING A CELL POPULATION ENRICHED IN NEURONS AND PRECURSORS THEREOF | Novo Nordisk A/S | MIANO, JOSEPH PAUL | 1631 | Non-Final OA | Jan 05, 2024 |
| 18568719 | A SINGLE DOSE INJECTION DEVICE | Novo Nordisk A/S | GILBERT, ANDREW M | 3700 | Non-Final OA | Dec 08, 2023 |
| 18289294 | INSULIN ON BOARD FOR GLUCOSE SENSITIVE INSULIN | Novo Nordisk A/S | SHAH, NILAY J | 3783 | Non-Final OA | Nov 02, 2023 |
| 18242868 | FACTOR X BINDERS ENHANCING FX ACTIVATION | Novo Nordisk A/S | SZPERKA, MICHAEL EDWARD | 1641 | Final Rejection | Sep 06, 2023 |
| 18274614 | NOVEL SYNTHESIS OF SALCAPROZIC ACID BY AMIDE FORMATION | Novo Nordisk A/S | CARR, DEBORAH D | 1691 | Non-Final OA | Jul 27, 2023 |
| 18037813 | FAST DATA TRANSMISSION FEATURE FOR MEDICAL LOGGING DEVICE | Novo Nordisk A/S | REGO, DOMINIC E | 2648 | Non-Final OA | May 19, 2023 |
| 18026136 | PHARMACEUTICAL FORMULATION OF CONCIZUMAB AND METHOD OF PRODUCTION THEREOF | Novo Nordisk Health Care AG | REDDIG, PETER J | 1646 | Non-Final OA | Mar 14, 2023 |
| 18022538 | METHOD FOR SCREENING IN VITRO POPULATION OF STEM CELL DERIVED BETA LIKE CELLS AND NOVEL MARKERS THEREOF | Novo Nordisk A/S | DHAR, MATASHA | 1632 | Non-Final OA | Feb 22, 2023 |
| 18017041 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | Novo Nordisk A/S | HA, JULIE | 1654 | Non-Final OA | Jan 19, 2023 |
| 18016947 | GLP-1 AND GIP RECEPTOR CO-AGONISTS | Novo Nordisk A/S | CHANDRA, GYAN | 1674 | Non-Final OA | Jan 19, 2023 |
| 18015444 | METHODS FOR TREATING CARDIOVASCULAR DISEASE | Novo Nordisk A/S | HOWARD, ZACHARY C | 1674 | Final Rejection | Jan 10, 2023 |
| 17913292 | Solid Dispersions of Amorphous 3,4-Diphenyl-4,5-Dihydro-1H-Pyrazole Derivatives, Compositions Comprising them and Uses Thereof as Cannabinoid CB1 Receptor Inhibitors | Novo Nordisk A/S | SAEED, KAMAL A | 1626 | Non-Final OA | Sep 21, 2022 |
| 17908750 | USE OF PLURIPOTENT MARKERS TO DETECT CONTAMINATING RESIDUAL UNDIFFERENTIATED PLURIPOTENT STEM CELLS | Novo Nordisk A/S | HANEY, AMANDA MARIE | 1682 | Non-Final OA | Sep 01, 2022 |
| 17800747 | GLP-1 COMPOSITIONS AND USES THEREOF | Novo Nordisk A/S | ATKINSON, JOSHUA ALEXANDER | 1612 | Non-Final OA | Aug 18, 2022 |
| 17833587 | METHODS FOR THE PURIFICATION OF PROTEINS USING CAPRYLIC ACID | Novo Nordisk A/S | BREEN, KIMBERLY CATHERINE | 1657 | Non-Final OA | Jun 06, 2022 |
| 17782249 | FIXED DOSE INJECTION DEVICE | Novo Nordisk A/S | GRASMEDER, SARAH DYMPNA | 3783 | Final Rejection | Jun 03, 2022 |
| 17782003 | AN INJECTION DEVICE FOR DELIVERING A LIQUID DRUG | Novo Nordisk A/S | NORTH, ISABELLA SARAH HYO SO | 3783 | Final Rejection | Jun 02, 2022 |
| 17616283 | APPLICATION OF ANTIARRHYTHMIC AGENTS TO STEM CELL DERIVED CARDIOMYOCYTES AND USES THEREOF | Novo Nordisk A/S | TRAN, KHOA NHAT | 1632 | Final Rejection | Dec 03, 2021 |
| 17512751 | Anti-IL-6 Antibody Formulation | Novo Nordisk A/S | BERHANE, SELAM | 1675 | Non-Final OA | Oct 28, 2021 |
| 17598010 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | Novo Nordisk A/S | HA, JULIE | 1654 | Non-Final OA | Sep 24, 2021 |
| 17403357 | COMPOSITIONS COMPRISING A DELIVERY AGENT AND PREPARATION THEREOF | Novo Nordisk A/S | REYNOLDS, FRED H | 1658 | Final Rejection | Aug 16, 2021 |
| 17270072 | SYSTEMS AND METHODS FOR PROVIDING CONTAINER BASED MEDICATION DOSE GUIDANCE TO TREAT DIABETES | Novo Nordisk A/S | ROSSI, VY BUI | 1685 | Final Rejection | Feb 22, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial